Article
CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo.
Journal for immunotherapy of cancer - 1 Jan 2017
Kueberuwa Gray, Gornall Hannah, Alcantar-Orozco Erik Marcelo, Bouvier Deborah, Kapacee Zainul Abedin, Hawkins Robert Edward, Gilham David Edward
Abstract excerpt
BACKGROUND: Adoptive T cell immunotherapy (ATCT) for cancer entails infusing patients with T cells that recognise and destroy tumour cells. Efficient engraftment of T cells and persistence in the circulation correlate with favourable clinical outcomes. T cells of early differentiation possess an increased capacity for proliferation and therefore persistence, using these cells for ATCT could therefore lead to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
